Growth Metrics

Idexx Laboratories (IDXX) Other Non-Current Liabilities (2016 - 2026)

Idexx Laboratories has reported Other Non-Current Liabilities over the past 17 years, most recently at $56.5 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 27.48% year-over-year to $56.5 million; the TTM value through Dec 2025 reached $56.5 million, up 27.48%, while the annual FY2025 figure was $56.5 million, 27.48% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $56.5 million at Idexx Laboratories, down from $57.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $85.0 million in Q2 2021 and troughed at $44.3 million in Q4 2024.
  • A 5-year average of $65.0 million and a median of $65.9 million in 2023 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 32.33% in 2024 and later increased 27.48% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $70.9 million in 2021, then fell by 4.73% to $67.6 million in 2022, then fell by 3.05% to $65.5 million in 2023, then crashed by 32.33% to $44.3 million in 2024, then increased by 27.48% to $56.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for IDXX at $56.5 million in Q4 2025, $57.6 million in Q3 2025, and $56.8 million in Q2 2025.